
To explore the effects of zzso dose on cancer risk reduction in patients with type 2 zzso 

zzso cohort zzso 

National Health Insurance program zzso Health Insurance zzso 

A total of zzso zzso and zzso patients without diabetes and no previous cancer diagnosis were extracted from the zzso 

We compared cancer risk among the subjects who had no diabetes, had type 2 diabetes but were not on diabetes drugs, used zzso only, used zzso drugs other than zzso or used zzso in combination with other zzso zzso Our results revealed zzso effects of zzso on cancer risk and cancer onset zzso A significant decrease in cancer risk was found in the zzso group who received more than 360 defined daily doses zzso of zzso zzso ratio zzso zzso zzso confidence zzso zzso zzso The greatest decrease in cancer risk was observed in patients who took more than zzso zzso zzso zzso zzso zzso zzso zzso greater zzso effects were seen in patients who used zzso in combination with other zzso zzso 

The magnitude of cancer risk reduction and prolonged cancer onset times produced by zzso in patients with type 2 diabetes depended on the dose of zzso regardless of whether zzso was used alone or combined with other zzso zzso 

